| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.07 |